Benchmarking Natural and Synthetic AAV Capsids for Neutralizing Antibody Evasion

被引：0
|
作者：
Donahoe, William [1 ]
Pacouret, Simon [1 ]
Brauer, Pamela P. [1 ]
Harvey, John W. [1 ]
Pirtle, Catherine P. [1 ]
Chan, Ken Y. [1 ]
Chan, Yujia A. [1 ]
Deverman, Benjamin E. [1 ]
机构：
[1] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1553
引用
收藏
页码：725 / 725
页数：1
相关论文
共 50 条
  • [1] Improvement of a neutralizing antibody assay for AAV capsids
    Watano, R.
    Ohba, K.
    Sehara, Y.
    Saga, Y.
    Urabe, M.
    Mizukami, H.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A313 - A313
  • [2] Novel AAV capsids show increased evasion to wild-type AAV9 neutralizing antibodies
    Kerns, S.
    Padegimas, L.
    Miller, T.
    HUMAN GENE THERAPY, 2019, 30 (11) : A119 - A119
  • [3] A Vector Independent Method of Neutralizing Antibody Evasion Potently Protects AAV for Efficient Gene Delivery
    Askew, Charles
    Li, Chengwen
    MOLECULAR THERAPY, 2020, 28 (04) : 22 - 22
  • [4] Directed Evolution of AAV for Enhanced Evasion of Human Neutralizing Antibodies
    Bartel, Melissa A.
    Hwang, Bum-Yeol
    Stone, Daniel
    Koerber, James T.
    Couto, Linda
    Mingozzi, Federico
    High, Katherine A.
    Schaffer, David V.
    MOLECULAR THERAPY, 2012, 20 : S140 - S140
  • [5] AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees
    Calcedo, Roberto
    Wilson, James M.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2016, 27 (02) : 79 - 82
  • [6] Discovery of TRACER AAV Capsids Escaping Pre-Existing Neutralizing Antibodies
    Maura, Damien
    Yu, Jennifer
    Ren, Xiao-Qin
    Child, Matthew
    Kaur, Rupinderjit
    Thorpe, Zachary
    Liu, Jiachen
    Gebremedhin, Netsanet
    Cox, Daniel Henry
    Chen, Weitong
    Hoffman, Brett
    Moyer, Tyler
    Sayed-Zahid, Ambreen
    Yao, Johnny
    Chung, Charlotte
    Carter, Todd A.
    Nonnenmacher, Mathieu E.
    MOLECULAR THERAPY, 2024, 32 (04) : 475 - 475
  • [7] Engineering of synthetic AAV capsids via rational assembly of "Virobytes"
    Boumezbeur, Ahmed-Hocine
    Grosse, Stefanie
    Grimm, Dirk
    HUMAN GENE THERAPY, 2014, 25 (11) : A83 - A83
  • [8] Neutralizing Antibodies Against AAV Capsids in Patients with Mut Methylmalonic Acidemia (MMA)
    Sloan, Jennifer L.
    Manoli, Irini
    Harrington, Elizabeth
    Chandler, Randy J.
    Schneider, Mark
    Calcedo, Roberto
    Wilson, James M.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2014, 22 : S73 - S73
  • [9] AAV.Ghost: Novel Stealth Capsid for Improved Central Nervous System Gene Delivery and Neutralizing Antibody Evasion
    Grimason, Haley C.
    Labdi, Lena
    Izzo, Cassandra M.
    Ungerleider, Justin
    Liu, Guyu
    St Louis, Pamela
    Batista, Ana Rita
    Gray-Edwards, Heather
    Sena-Esteves, Miguel
    MOLECULAR THERAPY, 2022, 30 (04) : 72 - 73
  • [10] Expanding the Serotype Frontier: Design of Synthetic AAV Capsids with Artificial Intelligence
    Sinai, Sam
    Brookes, David
    Chan, Jeffrey
    Mijalis, Alex
    Kern, Alex
    Prasad, Neha
    Sternlieb, Eodore
    Damani, Farhan
    Lin, Kathy S.
    Kwasnieski, Jamie
    Veres, Adrian
    Kelsic, Eric
    MOLECULAR THERAPY, 2024, 32 (04) : 691 - 692
12345